Literature DB >> 893773

Haemodynamic effects of dopamine in septic shock.

B Regnier, M Rapin, G Gory, F Lemaire, B Teisseire, A Harari.   

Abstract

The Haemodynamic response to dopamine infusion has been assessed in 30 patients in septic shock with myocardial dysfunction. Dopamine infusion resulted in a haemodynamic improvement as indicated by significant increases in cardiac output of 38.4% (p less than .001), stroke volume 18.7% (p less than .001), and mean arterial pressure of 33% (p less than .001). Despite the inotropic effect, left ventricular filling pressure did not change in 20 cases and increased in 10 cases. Mean peripheral resistance remained unchanged with a scatter of individual responses depending upon factors such as dopamine dose and initial vascular resistance. Dopamine increased intrapulmonary shunting by 48% (p less than .001), insignificantly decreased PaO2, increased mixed venous oxygen saturation by 16% (p less than .02) and decreased pulmonary vascular resistance by 15% (p less than .02). Both isoprenaline and dopamine improve stroke volume by an inotropic action, with an increase in venous return in the case of the latter and a reduction in afterload in the former. It is concluded that the usefulness of dopamine in septic shock may be limited in patients with previous myocardial disease because of the risk of increasing preload and in hypoxaemic patients because of the risk of increasing intrapulmonary shunting.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893773     DOI: 10.1007/bf01683060

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

Review 1.  Dopamine--clinical uses of an endogenous catecholamine.

Authors:  L I Goldberg
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

2.  Effects of dopamine on hemodynamics and renal function.

Authors:  A M Abrahamsen; L Storstein; L Westlie; O Storstein
Journal:  Acta Med Scand       Date:  1974-05

3.  Effectiveness of dopamine in patients with cardiogenic shock.

Authors:  J Holzer; J S Karliner; R A O'Rourke; W Pitt; J Ross
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

4.  Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.

Authors:  J Beregovich; C Bianchi; S Rubler; E Lomnitz; N Cagin; B Levitt
Journal:  Am Heart J       Date:  1974-05       Impact factor: 4.749

5.  Acute hemodynamic effects of dopamine in patients with shock.

Authors:  H S Loeb; E B Winslow; S H Rahimtoola; K M Rosen; R M Gunnar
Journal:  Circulation       Date:  1971-08       Impact factor: 29.690

6.  Hemodynamic studies and results of therapy in 50 patients with bacteremic shock.

Authors:  E J Winslow; H S Loeb; S H Rahimtoola; S Kamath; R M Gunnar
Journal:  Am J Med       Date:  1973-04       Impact factor: 4.965

7.  A hemodynamic comparison of dopamine and isoproterenol in patients in shock.

Authors:  R C Talley; L I Goldberg; C E Johnson; J L McNay
Journal:  Circulation       Date:  1969-03       Impact factor: 29.690

8.  Abnormal vascular tone, defective oxygen transport and myocardial failure in human septic shock.

Authors:  J H Siegel; M Greenspan; L R Del Guercio
Journal:  Ann Surg       Date:  1967-04       Impact factor: 12.969

9.  Dopamine in the treatment of hypotension and shock.

Authors:  K L MacCannell; J L McNay; M B Meyer; L I Goldberg
Journal:  N Engl J Med       Date:  1966-12-22       Impact factor: 91.245

10.  Action of drugs in patients early after cardiac surgery. I. Comparison of isoproterenol and dopamine.

Authors:  E L Holloway; E B Stinson; G C Derby; D C Harrison
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

View more
  20 in total

1.  Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport.

Authors:  S J Mackenzie; F Kapadia; G R Nimmo; I R Armstrong; I S Grant
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines.

Authors:  T Lherm; G Troché; M Rossignol; P Bordes; J F Zazzo
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 3.  Inotropic drugs in acute circulatory failure.

Authors:  P Herbert; J Tinker
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

4.  Pharmacological treatment of pulmonary oedema.

Authors:  J Carlet; M Francoual; F Lhoste; B Regnier; F Lemaire
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

5.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

6.  Hyperkinetic shock in viral and pneumococcal pneumonias.

Authors:  J Dussan; B Regnier; T Darragon; B Teisseire; J R Le Gall; F Lemaire
Journal:  Intensive Care Med       Date:  1979-05       Impact factor: 17.440

7.  Dobutamine in elderly septic shock patients refractory to dopamine.

Authors:  B Tell; T C Majerus; L Flancbaum
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

8.  Circulating immune complexes in patients with gram negative septic shock.

Authors:  C George; J Carlet; A Sobel; L Intrator; M Robin; C Sabatier; D Prevot; M Rapin
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

9.  [Surgical intensive care medicine. Current therapy concepts for septic diseases].

Authors:  A D Niederbichler; K Ipaktchi; A Jokuszies; T Hirsch; M A Altintas; A E Handschin; K H Busch; M Gellert; H-U Steinau; P M Vogt; L Steinsträsser
Journal:  Chirurg       Date:  2009-10       Impact factor: 0.955

10.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy
Journal:  Intensive Care Med       Date:  2004-03-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.